欄目導(dǎo)航
      
            avigation
            
    
            
    
  
            
  
            
    
    
            
      
            
        
            
           
            
           
              
            
           

            
        
        
       
            
      
      
            
        
            olchemim Labelled plant growth regulators Cytokini
            
        
            發(fā)布時間：2024-06-13
            
        
            訪問次數(shù)：1432
            
        
            公司地址：廣州市天河區(qū)天河北路僑林街47號中旅商務(wù)大廈東塔25E
            
        
            產(chǎn)品價格：來電咨詢
            
      
            
    
            
    
            產(chǎn)品詳情在線留言
            
    
             
    

                
            
                	
                    
            
                        
                            
                        
                    
            
                
            The labelled natural cytokinins can be distinguished in the MS analysis because the m/z values of their mass spectral fragments are displaced by several mass units (m/z > 2 amu). A known quantity of the labelled cytokinin is added to the initial extract, and after purification the molar ratio of natural cytokinin to labelled internal standard is determined by mass spectrometry. The quantitative analysis by MS was first carried out by Thompson et al., Planta, 124: 207, 1975.
            [15N5]ADENINE (15N-Ade) [6-amino[15N5]purine]
            MW 139.10; crystalline; purity > 97% (HPLC)
            R:22, S:22, 36; C5H515N5
             
            ADENINE 
            030 02411mg
            030 02422mg
            030 02435mg
            [2H7]N6-BENZYLADENINE (D-BA) [6-[2H7]benzylaminopurine]
            MW 232.29; crystalline; purity > 97% (HPLC)
            R:36/37/38, S:26, 36; CAS: 147028-87-3; C12H42H7N5
            BENZYLADENINE
            030 02211mg
            030 02222mg
            030 02235mg
            [2H7]N6-BENZYLADENOSINE (D-BAR) [6-[2H7]benzylamino-9-β-D-ribofuranosylpurine]
            MW 364.41; crystalline; purity > 97% (HPLC)
            S:26, 36; C17H122H7N5O4
            BENZYLADENOSINE
            030 05511mg
            030 05522mg
            030 05535mg
            [2H7]N6-BENZYLADENINE-9-GLUCOSIDE (D-BA9G) [6-[2H7]benzylamino-9-β-D-glucopyranosylpurine]
            MW 394.44; crystalline; purity > 97% (HPLC)
            R: 36/37/38, S: 26, 36; C18H142H7N5O5
            N6-BENZYLADENINE-9-GLUCOSIDE(D-BA9G)
            030 32811mg
            030 32822mg
            030 32835mg
            [2H7]N6 - BENZYLADENOSINE-5'-MONOPHOSPHATE SODIUM SALT (D-BAMP) [6-[2H7]benzylamino-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]
            MW 506.38; crystalline; purity > 95% (HPLC)
            S:26, 36; C17H112H7N5Na2O7P.H2O
            N6 a€“ BENZYLADENOSINE-5'-MONOPHOSPHATE SODIUM SALT (D-BAMP)
            030 50011mg
            030 50022mg
            030 50035mg
            [2H3]DIHYDROZEATIN (D-DHZ) [6-[2H3](4-hydroxy-3-methylbutylamino)purine]
            MW 224.28; crystalline; purity > 98% (HPLC)
            S:26, 36; CAS: 175733-30-9; C10H122H3N5O
             DIHYDROZEATIN (D-DHZ)
            030 06011mg
            030 06022mg
            030 06035mg
            [15N-N4]DIHYDROZEATIN (15N-DHZ) [6-[15N-N4](4-hydroxy-3-methylbutylamino)purine]
            MW 225.24; crystalline; purity > 98% (HPLC)
            S:26, 36; C10H12N15N4O
             DIHYDROZEATIN (N-DHZ)
            030 70211mg
            030 70222mg
            030 70235mg
            [2H3]DIHYDROZEATIN RIBOSIDE (D-DHZR)[6-[2H3](4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosylpurine]
            MW 356.40; crystalline; purity > 97% (HPLC)
            S:26, 36; CAS: 175733-31-0; C15H202H3N5O5
            DIHYDROZEATIN RIBOSIDE (D-DHZR)
            030 06111mg
            030 06122mg
            030 06135mg
            [2H3]DIHYDROZEATIN RIBOSIDE-5'-MONOPHOSPHATE (D-DHZMP) [6-[2H3](4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosyl purine-5'-monophosphate disodium monohydrate]
            MW 498.36; crystalline; purity > 95% (HPLC)
            S:26, 36; C15H192H3N5Na2O8P.H2O
            DIHYDROZEATIN RIBOSIDE-5'-MONOPHOSPHATE (D-DHZMP)
            030 50111mg
            030 50122mg
            030 50135mg
            [2H3]DIHYDROZEATIN-9-GLUCOSIDE (D-DHZ9G)[6-[2H3](4-hydroxy-3-methylbutylamino)-9-β-D-glucopyranosylpurine]
            MW 386.43; crystalline; purity > 95% (HPLC)
            S:26, 36; C16H222H3N5O6
            DIHYDROZEATIN-9-GLUCOSIDE (D-DHZ9G) 
            030 06311mg
            030 06322mg
            030 06335mg
            [2H7]DIHYDROZEATIN-O-GLUCOSIDE (D-DHZOG) [6-[2H7](4-hydroxy-3-methylbytylamino)-O-β-D-glucopyranosylpurine]
            MW 390.45; crystalline; purity > 95% (HPLC)
            S:26, 36; C16H182H7N5O6
            DIHYDROZEATIN-O-GLUCOSIDE (D-DHZOG)
            030 06411mg
            030 06422mg
            030 06435mg
            [2H7]DIHYDROZEATIN-O-GLUCOSIDE RIBOSIDE (D-DZROG) [6-[2H7](4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosyl-O-β-D-glucopyranosylpurine]
            MW 522.56; crystalline; purity > 95% (HPLC)
            S:26, 36; C21H262H7N5O10
            DIHYDROZEATIN-O-GLUCOSIDE (D-DHZOG)
            030 06511mg
            030 06522mg
            030 06535mg
            [15N-N4]HYPOXANTINE (15N-Hyp) [6-[15N-N4]hydroxypurine]
            MW 140.09; crystalline; purity > 97% (HPLC)
            S:26, 36; C5H415N4O
             HYPOXANTINE (N-Hyp)
            030 59411mg
            030 59422mg
            030 59435mg
            [2H6]N6-ISOPENTENYLADENINE (D-iP) [6-[2H6](3,3-dimethylallylamino)purine]
            MW 209.29; crystalline; purity > 98% (HPLC)
            S:26, 36; CAS: 175733-28-5; C10H72H6N5
            N6-ISOPENTENYLADENINE (D-iP)
            030 01611mg
            030 01622mg
            030 01635mg
            [15N4-N6]-ISOPENTENYLADENINE (15N4-iP) [6-[15N4](3,3-dimethylallylamino)purine]
            MW 207.22; crystalline; purity > 98% (HPLC)
            S:26, 36; C10H1315N4N 
             
            ISOPENTENYLADENINE (15N4-iP)
            030 73711mg
            030 73722mg
            030 73735mg
            [2H6]N6-ISOPENTENYLADENOSINE (D-iPR) [6-[2H6](3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine]
            MW 341.41; crystalline; purity > 98% (HPLC)
            S:26, 36; CAS: 175733-29-6; C15H152H6N5O4
             
            N6-ISOPENTENYLADENOSINE (D-iPR)
            030 01711mg
            030 01722mg
            030 01735mg
            [15N]N6-ISOPENTENYLADENOSINE (15N-iPR) [6-[15N](3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine]
            MW 336.36; crystalline; purity > 98% (HPLC)
            S:26, 36; C15H21N415NO4 
             
            ISOPENTENYLADENOSINE (15N-iPR)
            030 70311mg
            030 70322mg
            030 70335mg
            [2H6]N6-ISOPENTENYLADENOSINE-5'-MONOPHOSPHATE (D-iPMP) [6[2H6]-(3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]
            MW 483.37; crystalline; purity > 95% (HPLC)
            S:26, 36; C15H142H6N5Na2O7P.H2O
            N6-ISOPENTENYLADENOSINE-5'-MONOPHOSPHATE (D-iPMP)
            030 50411mg
            030 50422mg
            030 50435mg
            [2H6]N6-ISOPENTENYLADENINE-7-GLUCOSIDE(D-iP7G)[6-[2H6] (3,3-dimethylallylamino)-7-β-D-glucopyranosylpurine]
            MW 371.43; crystalline; purity > 95% (HPLC)
            S:26, 36; C16H172H6N5O5
            N6-ISOPENTENYLADENINE-7-GLUCOSIDE (D-iP7G)
            030 50511mg
            030 50522mg
            030 50535mg
            [2H6] N6-ISOPENTENYLADENINE-9-GLUCOSIDE (D-iP9G) [6-[2H6] (3,3-dimethylallylamino)-9-β-D-glucopyranosylpurine]
            MW 371.43; crystalline; purity > 95% (HPLC)
            S:26, 36; C16H172H6N5O5
            N6-ISOPENTENYLADENINE-9-GLUCOSIDE (D-iP9G)
            030 02311mg
            030 02322mg
            030 02335mg
            [2H6]2-METHYLTHIO-N6-ISOPENTENYLADENINE (D-2MeSiP) [2-methylthio-6-[2H6](3,3-dimethylallylamin)purine]
            MW 255.38; crystalline; purity > 95% (HPLC)
            S:26, 36; C10H72H6N5S
            2-METHYLTHIO-N6-ISOPENTENYLADENINE (D-2MeSiP)
            030 50711mg
            030 50722mg
            030 50735mg
            [2H6]2-METHYLTHIO-N6-ISOPENTENYLADENOSINE (D-2MeSiPR) [2-methylthio-6-[2H6](3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine]
            MW 387.50; crystalline; purity > 95% (HPLC)
            S:26, 36; C16H172H6N5O4S
            2-METHYLTHIO-N6-ISOPENTENYLADENOSINE (D-2MeSiPR)
            030 50611mg
            030 50622mg
            030 50635mg
            [15N4]KINETIN(15N-K) [6-furfurylamino[15N4]purine]
            MW 219.19; CRYSTALLINE; purity > 97% (HPLC)
            S:26, 36; C10H9N15N4O
             
            KINETIN (15N-K )
            030 03411mg
            030 03422mg
            030 03435mg
            [15N-N4]meta-METHOXYTOPOLIN (15N-MemT) [6-(3-methoxybenzylamino)[15N4]purine]
            MW 259.25; crystalline; purity > 98% (HPLC)
            S:26, 36; C13H13N15N4O
             METHOXYTOPOLIN (MemT)
            030 05111mg
            030 05122mg
            030 05135mg
            [15N4]meta-TOPOLIN (15N-mT) [6-(3-hydroxybenzylamino)[15N4]purine]
            MW 245.23; CRYSTALLINE; purity >97% (HPLC)
            S:26, 36; C12H11N15N4O
             
            meta-TOPOLIN (mT)
            030 01011mg
            030 01022mg
            030 01035mg
            [15N4]ortho-TOPOLIN (15N-oT) [6-(2-hydroxybenzylamino)[15N4]purine]
            MW 245.23; CRYSTALLINE; purity >98% (HPLC)
            S:26, 36; C12H11N15N4O
             
            ortho-TOPOLIN (oT)
            030 01211mg
            030 01222mg
            030 01235mg
            [15N4]para-TOPOLIN (15N-pT) [6-(4-hydroxybenzylamino)[15N4]purine]
            MW 245.23; CRYSTALLINE; purity >98% (HPLC)
            S:26, 36; C12H11N15N4O
             
            para-TOPOLIN (pT)
            030 04511mg
            030 04522mg
            030 04535mg
            [2H5]trans-ZEATIN (D-tZ)[6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)purine]
            MW 224.28; crystalline; purity > 98% (HPLC); cis isomer <5%
            S:26, 36; CAS: 72963-19-0; C10H82H5N5O
             
            trans-ZEATIN (D-tZ)
            030 03011mg
            030 03022mg
            030 03035mg
            [15N]trans-ZEATIN (15N-tZ) [6-((E)-4-hydroxy-3-methylbut-2-enylamino) purine]
            MW 220.24; crystalline; purity > 98% (HPLC)
            S:26, 36; C10H13N415NO
            trans-ZEATIN (15N-tZ)
            030 70411mg
            030 70422mg
            030 70435mg
            [15N4]trans-ZEATIN (15N4-tZ) [6-[15N4]((E)-4-hydroxy-3-methylbut-2-enylamino) purine]
            MW 223.22; crystalline; purity > 98% (HPLC)
            S:26, 36; C10H1315N4NO
            trans-ZEATIN (15N4-tZ)
            030 73811mg
            030 73822mg
            030 73835mg
            [2H5]trans-ZEATIN RIBOSIDE (D-tZR) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine]
            MW 356.40; crystalline; purity > 97% (HPLC); cis isomer <0.2%
            S:26, 36; CAS: 72963-21-4; C15H162H5N5O5
            trans-ZEATIN RIBOSIDE (D-ZtR)
            030 03111mg
            030 03122mg
            030 03135mg
            [2H5]trans-ZEATIN-7-GLUCOSIDE (D-tZ7G) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-7-β-D-glucopyranosylpurine]
            MW 386.42; crystalline; purity > 95% (HPLC)
            S:26, 36; C16H182H5N5O6
            trans-ZEATIN-7-GLUCOSIDE (D-tZ7G)
            030 51111mg
            030 51122mg
            030 51135mg
            [2H5]trans-ZEATIN-9-GLUCOSIDE (D-tZ9G) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-glucopyranosylpurine]
            MW 386.42; crystalline; purity > 95% (HPLC)
            S:26, 36; CAS: 84744-92-3; C16H182H5N5O6
            trans-ZEATIN-9-GLUCOSIDE (D-tZ9G)
            030 04711mg
            030 04722mg
            030 04735mg
            [2H5]trans-ZEATIN-O-GLUCOSIDE (D-tZOG) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-O-β-D-glucopyranosylpurine]
            MW 386.42; crystalline; purity > 95% (HPLC)
            S:26, 36; CAS: 72963-23-6; C16H182H5N5O6
            trans-ZEATIN-O-GLUCOSIDE (D-tZOG)
            030 51211mg
            030 51222mg
            030 51235mg
            [2H5]trans-ZEATIN-O-GLUCOSIDE RIBOSIDE (D-tZROG) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosyl-O-β-D-glucopyranosylpurine]
            MW 518.54; crystalline; purity > 95% (HPLC)
            S:26, 36; CAS: 69700-29-4; C21H262H5N5O10
            trans-ZEATIN-O-GLUCOSIDE RIBOSIDE (D-tZROG)
            030 51311mg
            030 51322mg
            030 51335mg
            [2H5]trans-ZEATIN RIBOSIDE-5'-MONOPHOSPHATE (D-tZMP) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]
            MW 498.29; crystalline; purity > 95% (HPLC)
            S:26, 36; C15H152H5N5Na2O8P.H2O
            trans-ZEATIN RIBOSIDE-5'-MONOPHOSPHATE (D-ZMP)
            030 51411mg
            030 51422mg
            030 51435mg
            [2H5]2-METHYLTHIO-trans-ZEATIN (D-2MetSZ) [2-methylthio-6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)purine]
            MW 270.37; crystalline; purity > 95% (HPLC)
            S:26, 36; C11H102H5N5OS
            2-METHYLTHIO-trans-ZEATIN (D-2MetSZ)
            030 51711mg
            030 51722mg
            030 51735mg
            [2H5]2-METHYLTHIO-trans-ZEATIN RIBOSIDE (D-2MeStZR) [2-methylthio-6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine]
            MW 402.49; crystalline; purity > 95% (HPLC)
            S:26, 36; C16H182H5N5O5S
            2-METHYLTHIO-trans-ZEATIN RIBOSIDE (D-2MeStZR)
            030 51811mg
            030 51822mg
            030 51835mg
            [15N4]cis-ZEATIN (15N-cZ) [6-[15N4]((Z)-4-hydroxy-3-methylbut-2-enylamino) purine]
            MW 223.22; crystalline; purity > 98% (HPLC)
            S:26, 36; C10H13N15N4O
            cis-ZEATIN (15N-cZ)
            030 03211mg
            030 03222mg
            030 03235mg